Skip to content
OpenCapital
Get started

Conduit Pharmaceuticals CDT Q1 2026 Annual earnings

Reported July 2, 2026 · Before market open

Revenue$696.4MDiluted EPS$13.10

Next report

Date not yet announced

Versus estimates

Revenue

Q1 2026$696.4M

Diluted EPS

Q1 2026$13.10
Q4 2025-$99.99Q3 2025-$13.16Q2 2025-$43.68Q1 2025-$158.32Q4 2024-$2,438.38

Ask the moment Conduit Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Conduit Pharmaceuticals report Q1 2026 earnings?
Conduit Pharmaceuticals (CDT) reported Q1 2026 earnings on July 2, 2026 before market open.
What were Conduit Pharmaceuticals's Q1 2026 revenue and EPS?
Conduit Pharmaceuticals reported revenue of $696.4M and diluted EPS of $13.10 for Q1 2026.
Where can I find Conduit Pharmaceuticals's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-031093) and the 10-K periodic report (0001493152-26-016858) directly on SEC EDGAR. The filing index links above go to sec.gov.